Ibnsina to distribute Novartis’ Alcon products in Egypt: Ibnsina Pharma will distribute global eye care product manufacturer Novartis’ Alcon’s products in Egypt, according to a company statement (pdf). The newly inked agreement lends further credence to the argument “that exclusivity is dying in the pharma market,” Ibnsina Co-CEO Omar Abdel Gawad says. As the fastest growing distributor in Egypt, suppliers who want to grow at or above the market growth rate, have to contract with Ibnsina Pharma to achieve their targets.”
More from Enterprise
Banque du Caire’s blockbuster IPO holds firm against EGX selloff
The IFC and the EBRD are in for USD 100…
Can AI promise Egypt’s lenders more borrowers and fewer bad loans?
Banks are cautious about letting AI judge a borrower. Local…
Egypt’s funds crossed EGP 500 bn in 3Q on retail money and a stalling core
Money market funds stalled while retail piled into equity, index,…
DPI closes Egypt-born fintech fund Nclude at USD 112 mn
The final close adds roughly USD 7 mn to a…